Collaboration and License Agreements (Tables)

6 Months Ended

Jun. 30, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Summary of Revenue from Collaboration and License Agreements

We have recognized revenue from our collaboration and license agreements as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2016		2015		2016		2015
Daiichi Sankyo	$	1,297	$	1,142	$	4,681	$	2,271
Bayer and Janssen		807		807		4,115		1,606
BMS and Pfizer		1,733		384		2,987		763
Bayer		394		—		654		—
Lee’s Pharmaceutical		—		52		52		104
Total collaboration and license revenue	$	4,231	$	2,385	$	12,489	$	4,744